Randomized Trial of E-mail Follow-up Care After Cognitive Behavioural Treatment for Depression
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 92
- 试验地点
- 2
- 主要终点
- Measure of the severity of depression - Beck Depression Inventory (BDI- II)
研究概览
简要总结
The primary objective of this study is to test in a randomized effectiveness trial if e-mail delivered cognitive behavioural treatment is an effective follow-up care approach in the treatment of depression under clinically representative conditions.
详细描述
Depression belongs to the most prevalent mental disorders and often goes along with a high burden of disease. Although the efficacy and the effectiveness of psychological treatments for depressive disorders have been demonstrated, there remains the problem of maintaining the benefits achieved during the initial treatment phase. Therefore options of follow-up care have to be considered. Since access to psychotherapeutic treatments is limited and costly, internet-based interventions can offer a feasible opportunity for follow-up care in order to enhance the long-term effectiveness of psychotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Depressive disorder: F32.0-F32.2; F33.0-F33.2; F34.1 according to ICD-10
- •Precursory CBT
- •Internet access
排除标准
- •No knowledge of the German language
- •Risk of suicide
- •Acute psychosis or psychotic symptoms
- •Established concurrent in vivo CBT after discharge from inpatient CBT
结局指标
主要结局
Measure of the severity of depression - Beck Depression Inventory (BDI- II)
时间窗: Change in the BDI-II from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
次要结局
- Depressive relapse/recurrence(Measured at follow up (3 months after termination of the follow-up care))
- Measure of health related quality of life - SF-8(Change in the SF-8 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care)
- GAD-7(Change in the GAD-7 from baseline (beginning of treatment) to follow up (3 months after termination of the follow-up care))
研究者
PD Dr. phil. Birgit Watzke
Principal Investigator
Universitätsklinikum Hamburg-Eppendorf
